Fresenius Medical Care (NYSE:FMS) Shares Gap Up – Here’s What Happened

Fresenius Medical Care AG (NYSE:FMS)’s share price gapped up before the market opened on Thursday . The stock had previously closed at $24.73, but opened at $25.85. Fresenius Medical Care shares last traded at $25.74, with a volume of 96,490 shares.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on FMS shares. Truist Financial lifted their target price on shares of Fresenius Medical Care from $23.00 to $25.00 and gave the company a “hold” rating in a report on Monday, January 6th. StockNews.com raised shares of Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, February 5th.

Fresenius Medical Care Price Performance

The firm has a market capitalization of $15.18 billion, a price-to-earnings ratio of 21.37, a PEG ratio of 0.76 and a beta of 0.93. The stock’s 50-day moving average price is $24.13 and its 200 day moving average price is $22.61. The company has a quick ratio of 1.02, a current ratio of 1.37 and a debt-to-equity ratio of 0.42.

Institutional Investors Weigh In On Fresenius Medical Care

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Charles Schwab Investment Management Inc. grew its holdings in Fresenius Medical Care by 11.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 22,161 shares of the company’s stock valued at $472,000 after buying an additional 2,233 shares in the last quarter. Glenmede Trust Co. NA acquired a new position in Fresenius Medical Care in the 3rd quarter valued at about $271,000. Verition Fund Management LLC purchased a new stake in shares of Fresenius Medical Care during the 3rd quarter valued at approximately $237,000. Quantinno Capital Management LP grew its position in Fresenius Medical Care by 78.9% in the third quarter. Quantinno Capital Management LP now owns 110,078 shares of the company’s stock worth $2,345,000 after acquiring an additional 48,554 shares during the period. Finally, Virtus Investment Advisers Inc. purchased a new stake in Fresenius Medical Care in the third quarter valued at $226,000. Institutional investors and hedge funds own 8.37% of the company’s stock.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.